Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2003
10/30/2003WO2003088900A2 Solid forms of salts with tyrosine kinase activity
10/30/2003WO2003088765A2 Functional foods containing a phospholipid-containing stable matrix
10/30/2003WO2003088761A2 Physiologically compatible, phospholipid-containing, stable and hard matrix
10/30/2003WO2003088749A1 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
10/30/2003WO2003066629A3 Heteroaryl compounds useful as inhibitors of gsk-3
10/30/2003WO2003063796A3 Heterocyclic arylsulfonamidobenzylic compounds
10/30/2003WO2003051833A3 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
10/30/2003WO2003051293A3 Antidiabetic formulation and method
10/30/2003WO2003051277A3 Novel compounds
10/30/2003WO2003048148A3 Statin-like compounds
10/30/2003WO2003047421A3 Methods and reagents for diagnosis and treatment of diabetes
10/30/2003WO2003025199A3 Mid 4460, a human tyrosine phosphatase family member and uses therefor
10/30/2003WO2003016549A3 Nucleic-acid associated proteins
10/30/2003WO2003004501A3 (hetero) aryl substituted benzofurans as 5-ht ligands
10/30/2003WO2002097030A3 Peptides derived from neural thread proteins and their medical use
10/30/2003WO2002072004A3 Implantable artificial organ and physiological monitoring system
10/30/2003WO2002070741A3 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna
10/30/2003WO2002066476A9 6-phenylbenzonaphthyridines
10/30/2003WO2002064784A3 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter
10/30/2003WO2002064136A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/30/2003WO2002062833A3 Modified leptin with reduced immunogenicity
10/30/2003WO2002042303A3 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003WO2002032447A3 Cell damage inhibitor
10/30/2003WO2002026826A3 Proteins and nucleic acids encoding same
10/30/2003WO2002002638A3 Methods for treating rheumatic diseases using a soluble ctla4 molecule
10/30/2003US20030204863 Nav2 channel gene-deficient non-human animals
10/30/2003US20030204063 Growth hormone releasing factor; somatostatins; glucagon-like peptides; adrenocorticotropic hormones; atriopeptins; vasoactive intestinal peptides; for glucose intolerance associated with insulin resistance
10/30/2003US20030204052 Comprises polypeptide for treatment and prevention of autoimmune, cancer, inflammatory, nervous system, cardiomyopathy and atherosclerotic disorders
10/30/2003US20030203973 Administering triethylenetetramine to lower copper value of myocardium; for treatment of diabetes
10/30/2003US20030203966 Such as N-(3,5-dimethyl-4-((nitromethyl)sulphonyl) phenyl)benzenesulphonamide for treatment/prevention of peripheral and autonomous neurolgical diabetic complications, renal and ocular disorders (cataracts, retinopathy)
10/30/2003US20030203964 Process for producing medicaments which comprise HMG CoA reductase inhibitors
10/30/2003US20030203957 Selected fused pyrrolocarbazoles
10/30/2003US20030203955 Administering to a patient suffering from an immune cell mediated diseases a therapeutic amount of biheterocyclic compound containing sulfone group or substituted suflone
10/30/2003US20030203954 Substituted 3, 5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
10/30/2003US20030203947 Activator of PPAR delta
10/30/2003US20030203946 Glucagon antagonists/inverse agonists
10/30/2003US20030203926 For treatment of inflammatory or autoimmune condition, viral infection, cancer
10/30/2003US20030203922 Substituted amine derivatives and methods of use
10/30/2003US20030203920 Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof
10/30/2003US20030203919 Dipeptide nitrile cathepsin K inhibitors
10/30/2003US20030203915 Compounds that are nitrosated and/or nitrosylated through one or more sites such as oxygen (hydroxyl condensation), sulfur (sulfhydryl condensation) and/or nitrogen
10/30/2003US20030203913 Beta3 adrenergic receptor agonists and uses thereof
10/30/2003US20030203906 Novel substituted diamine derivatives useful as motlin antagonists
10/30/2003US20030203905 Inhibitors of p38
10/30/2003US20030203898 Therapeutic treatment and/or prophylaxis of arteriosclerosis and hypercholesterolaemia
10/30/2003US20030203895 Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
10/30/2003US20030203893 Benzimidazole derivatives, preparation and therapeutic use thereof
10/30/2003US20030203892 A synergistic therapeutic treatment for hypercholesterolemic condition
10/30/2003US20030203882 For treating psoriasis, inflammation, leukemia, colon cancer, breast cancer or prostate cancer
10/30/2003US20030203878 Comprises non-hydrated hydrogel, superdisintegrant, and tannic acid; for treatment of metastatic bone diseases (hypercalcemia)
10/30/2003US20030203877 Such as dipyroxylamine; for treating and preventing chronic tissue damage and diabetic complications (dialysis-related pathologies, proteinuria, impaired glomerular clearance, diabetic nephropathy, and protein crosslinking)
10/30/2003US20030203855 17-Aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
10/30/2003US20030203854 Composition for effecting serum cholesterol levels
10/30/2003US20030203850 Transdifferentiation of pancreatic acinar cells
10/30/2003US20030203842 Apolipoprotein A-l agonists and their use to treat dyslipidemic disorders
10/30/2003US20030203373 Method for identifying a pharmacologically active substance
10/30/2003US20030203052 Superoxide dismutase-containing cucumber extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance can be used by the topical or oral route; antiallergens; sunscreen agents; foods; drugs; cosmetics
10/30/2003US20030203051 Plant extracts for the treatment of increased bone resorption
10/30/2003US20030203013 Microbial cellulose wound dressing for treating chronic wounds
10/30/2003US20030203004 Dietetics; controlling appetite
10/30/2003US20030202976 Methods and reagents for diagnosis and treatment of diabetes
10/30/2003US20030202971 Genetic engineering; binding polypeptide to antibody ; screening, modulation, calibration
10/30/2003EP1496982A2 Solid forms of salts with tyrosine kinase activity
10/30/2003CA2770411A1 Aerosol containing a particulate active substance
10/30/2003CA2483409A1 (20s)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin d3 and their uses
10/30/2003CA2482991A1 Imidazo[1,2-a]pyrazin-8-ylamines method of making and method of use thereof
10/30/2003CA2482714A1 Indane acetic acid derivatives and their use as pharmaceutical agents
10/30/2003CA2482464A1 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
10/30/2003CA2482022A1 Novel compounds
10/30/2003CA2481940A1 (1-4-piperidinyl) benzimidazole derivatives useful as histamine h3 antagonists
10/30/2003CA2481120A1 Method for treating and preventing hyperparathyroidism
10/30/2003CA2480451A1 New 2-substituted -1,3-thiazole compounds
10/30/2003CA2480437A1 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/30/2003CA2480325A1 Solid forms of salts with tyrosine kinase activity
10/30/2003CA2478991A1 Compositions and methods for augmenting kidney function
10/29/2003WO2002092081A1 Method of treatment
10/29/2003EP1357186A1 Novel proteins and dnas thereof
10/29/2003EP1357115A1 Alkanoic acid derivatives, process for their production and use thereof
10/29/2003EP1357104A1 Tropolone derivative
10/29/2003EP1356819A1 Use of proteasome/ubiquitination inhibitors and/or MMP inhibitors alone or in combination with a growth hormone for treating /preventing catabolic conditions
10/29/2003EP1356276A2 Acetyl-coenzyme a carboxylase 2 as a target in the regulation of fat burning, fat accumulation, energy homeostasis and insulin action
10/29/2003EP1356079A2 Srebp pathway modulation through targeting hisrs
10/29/2003EP1356058A2 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356046A2 Cytokine receptor zcytor19
10/29/2003EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
10/29/2003EP1356042A2 Carbohydrate-associated proteins
10/29/2003EP1356032A2 Human kinases
10/29/2003EP1356024A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
10/29/2003EP1355943A2 Neurotransmitter transporters
10/29/2003EP1355942A2 Glp-1 fusion proteins
10/29/2003EP1355936A2 Polymer conjugates of neublastin and methods of using same
10/29/2003EP1355922A2 Stress proteins and peptides and methods of use thereof
10/29/2003EP1355909A2 Dihydropyrazolopyridine compounds and pharmaceutical use thereof
10/29/2003EP1355908A1 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them
10/29/2003EP1355907A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355902A1 Sulfonamide compounds, their preparation and use
10/29/2003EP1355891A2 Therapy
1 ... 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 ... 1298